StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) stock

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.15+0.02 (+1.77%)

Close on Nov 12, 2026Market cap $347.67MP/E –Yield –

ProKidney enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

ProKidney's enterprise value was -$110.77M on Jan 31, 2024.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2024Jan 31, 2024-$110.77M–
2023Dec 29, 2023-$81.85M–

More ProKidney figures

See a number that looks wrong?